Blum Holdings, Inc. (BLMH)

Healthcare · OID · US

$0.200.00% today

Price as at 30 Sept 2026, 16:34 UTC. Quotes are delayed.

Fundamentals

Market cap$6.31M
P/E ratio0.3
Revenue growth (YoY)+11.1%
Profit margin78.1%
52-week range$0.11 to $0.75

Valuation and ratings

Moat score52/100
Overall rating46/100, moderate quality

Blum Holdings, Inc. trades at $0.20. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.

Our moat model scores it 52 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

It changes hands at 0.3 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.

About Blum Holdings, Inc.

Blum Holdings, Inc., through its subsidiaries, engages in the retail and distribution of cannabis products in the United States. It operates through two segments, Cannabis Retail and Cannabis Distribution. The company offers cannabis products, including flower, edibles, and concentrates under the Korova brand. It also operates retail stores under the Cookies Sacramento brand; and medical marijuana retail and adult use dispensaries and distribution facilities. In addition, the company provides advisory and consulting services for dispensaries. The company was formerly known as Unrivaled Brands, Inc. and changed its name to Blum Holdings, Inc. in January 2024. Blum Holdings, Inc. was founded in 2010 and is headquartered in Downey, California.

Industry: Pharmaceutical RetailersEmployees: 133HQ: United States

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

BLMH passes 2 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

BLMH peers

The largest companies in the same industry (Pharmaceutical Retailers), then in the same sector.

Every healthcare company we cover is on the Healthcare hub.

Common questions

What is BLMH's P/E ratio?

BLMH trades at 0.3 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.

Where does SteadyShares get its BLMH data?

Fundamentals for BLMH come from company filings and exchange data, as listed on OID; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 16:34 UTC and is delayed. Our data quality score for this company is 71/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for BLMH, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.